Evaluation of Tumor-Induced Osteomalacia with
Journal of Nuclear Medicine Technology
177Lu-DOTATATE PRRT as promising new treatment approach in Recurrent Skull Base Phosphaturic Mesenchymal Tumor causing paraneoplastic oncogenic osteomalacia: a potential therapeutic application of PRRT beyond NET. SANDIP BASU et al., …

X